Marex Group’s Pfizer PFE Stock Holding History

Marex Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.25M	Buy	+80,000	New	+$2.13M	0.01%	310

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Marex Group's PFE Position: Q1 2026 in Review

Marex Group increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $785K and bringing the position to 245,068 shares worth $6.88M. The position accounts for 0.04% of the portfolio, ranked #193.

Marex Group first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Marex Group held 245,068 shares of Pfizer worth $6.88M as of Q1 2026.
Marex Group bought 29,486 Pfizer shares in Q1 2026, an estimated $785K.
Pfizer made up 0.04% of Marex Group's portfolio in Q1 2026, its #193 holding.
Marex Group first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.